US FDA approves Mesoblast cell therapy for graft-versus-host disease By Reuters
(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Mesoblast's (NASDAQ:) cell therapy to treat a type of ...
Tag: Mesoblast
Recommended.
